Navigation Links
Scripps Research scientists observe human neurodegenerative disorder in fruit flies
Date:6/24/2009

y Drosophila melanogaster, which caused the insect to develop a condition with several of the hallmarks of the human disease. This suggests that Charcot-Marie-Tooth disease is related to some fundamental and unknown function the protein plays in the development and homeostasis of the nervous system. Because the unknown function is common to both humans and flies, it probably evolved hundreds of millions of years ago before the ancient ancestors of humans and flies diverged.

What exactly this function is for is still unknown. "That is a great mystery," says Schimmel. He adds that the genetically altered fruit flies are a convenient and powerful model system that may be able to help answer this question.


'/>"/>

Contact: Keith McKeown
kmckeown@scripps.edu
858-784-8134
Scripps Research Institute
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Scripps studies offer new picture of Lake Tahoes earthquake potential
2. Scripps scientists help decode mysterious green glow of the sea
3. Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy
4. Scripps research scientists watch as individual alpha-synuclein proteins change shape
5. Scripps research team identifies key molecules that inhibit viral production
6. Historical photographs expose decline in Floridas reef fish, new Scripps study finds
7. Scripps scientists create first crystal structure of an intermediate particle in virus assembly
8. Scripps scientists develop first examples of RNA that replicates itself indefinitely
9. Scripps Research scientists shed light on how DNA is unwound so that its code can be read
10. Dolphin population stunted by fishing activities, Scripps/NOAA study finds
11. Scripps research team defines new painkilling chemical pathway

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... ALBUQUERQUE, N.M. Most scientists believe that s... that signal each other to emit toxins. The signal...bacteria must be present to start the process. , ...d that the very first stage of staph infection, wh...orm, occurs in a single cell and that this individ...
(Date:12/3/2009)...ave you ever felt overly upset by a social snubbin...t. , Scientists have long known that opium-like ...ical pain, but also some forms of emotional stress...logy member Markus Heilig shows that small genetic...an determine the intensity of people,s responses t...
(Date:12/3/2009)...he UK leads the world when it comes to investment ...ineering and Physical Sciences Research Council (E...e is needed: "Scientific and engineering research ...d solar power solutions, but more investment is ne...tions if we are to meet our carbon emission target...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Research is vital to a cleaner, greener, low carbon future 2University of Miami facility awarded prestigious LEED Green Building Certification 10497 1University of Miami facility awarded prestigious LEED Green Building Certification 10497 2University of Miami facility awarded prestigious LEED Green Building Certification 10497 3Coffee May Slow Liver Disease 59983 1Coffee May Slow Liver Disease 59983 2Sanford Barsky M D University of Nevada School of Medicine and Nevada Cancer Institute faculty member publishes scientific paper in the journal Nat 59979 1Sanford Barsky M D University of Nevada School of Medicine and Nevada Cancer Institute faculty member publishes scientific paper in the journal Nat 59979 2
...work , Many herbal plants such as strawberry, clov... Individual plants remain connected with each othe.... These connections enable the plants to share inf...ey are therefore very similar to computer networks...out? , Recently Stuefer and his colleagues were t...
...s have discovered how the zebrafish (Danio rerio) ...s add to the growing list of tasks carried out by ...ngement of everything from nerve cells to reproduc...ch focused on a particular zebrafish mutant known ... four stripes running down its side is missing, an...
..., Ill. By better understanding how antimicrobials...air passages, researchers at the University of Ill... patients fight off deadly infections., While not ...trategy against bacterial infections in cystic fib...cience and engineering, of physics, and of bioengi...
Other Biology News:Study shows how the zebrafish gets his stripe 2Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials 2
(Date:12/3/2009)...HOPKINTON, Mass., Dec. 3 ...eading provider of tools and services for drug dis...d Living Image 4.0 software for IVIS® in vivo... more than 800 Caliper IVIS systems currently inst...features advanced spectral unmixing tools to enhan...
(Date:12/2/2009)..., NEW YORK, Dec. 2 Reportlinker...s available in its catalogue: ,, Carbondioxide...http://www.reportlinker.com/p0164368/Carbondioxide..., Incubators are the most critical equipment us...d other applications for providing a controlled en...
(Date:12/2/2009)..., CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Onco...) (TSX:ONC; NASDAQ: ONCY ) announced today that in...ering, the underwriters have exercised in full the...al 637,500 units. Each unit is comprised of one co...ant, and was sold at a price of US$3.00 per unit. ...
(Date:12/2/2009)..., SINGAPORE, Dec. 2 S*BIO Pte Lt...oral JAK2 inhibitor, SB1518, at The American Socie...n in New Orleans. ,, Data will be presented on ...ion trial of SB1518 detailing its safety, tolerabi...rofile in dose levels ranging from 100 to 600 mg. ...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
...esults (all percentage comparisons are to comparab...w Quarterly Record: Q1 2008 sales reached a new ...e of 14.9%, with all four business units al... reporting double-digit growth for the quarter. ...y a currency benefit of 7.6% and a 0.8% con...
... April 22, GlaxoSmithKline (NYSE: GSK ) and Sirtr...nnounced today that they have,entered into a defin...will,acquire Sirtris Pharmaceuticals for approxima...rough a cash tender offer of USD22.50 (or approx.,...Sirtris, GSK will significantly enhance its,metabo...
...TRIANGLE PARK, N.C., April 22 Quintiles,Transnati...e new practice,leaders and a business development ... business, which provides pharmaceutical, biotech ...ce to maximize potential and minimize,risk from ea...es Consulting is expanding its current services an...
Other Biology Technology:Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 2Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 3Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 4Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 5Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 6Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 7Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 8Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 9Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 10Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 11Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 12Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 13Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 14Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 15Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 16Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 17Sigma-Aldrich (Nasdaq: SIAL) Raises 2008 Diluted EPS Forecast by $.05 to $2.57-$2.67. Reports Q1 2008 Diluted EPS Up 14.3%; Sales Gain of 14.9%. 18GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development 2GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development 3GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development 4Quintiles Consulting Business Expands 2Quintiles Consulting Business Expands 3Quintiles Consulting Business Expands 4
... clone 8G8/5 GenBank Accession Number : NM_002542...ma fusion protein corresponding to residues 166-22...an AP-2γ Formulation: 0.1M Tris-glycine, pH ...ition of glycerol to 30% Quality Assurance: routin...
Rabbit Anti-Human Secretory Carrier Membrane Protein 2 (SCAMP2) Polyclonal Antibody, Unconjugated from Lifespan Biosciences
Mouse Anti-Mucin 3 (MUC3) Ab-2 Monoclonal Antibody, Unconjugated, Clone 1143/B7 from Lab Vision
...the caudal-related homeobox family, is an intestin...h proliferation and differentiation in intestinal ...iggering cells towards the phenotype of differenti...nce of the phenotype. Clone CDX2-88 reacts with a ...
Biology Products: